rs145712124
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PP3_ModerateBP6BS2
The NM_006514.4(SCN10A):c.2428G>T(p.Gly810Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000575 in 1,614,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G810G) has been classified as Likely benign.
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN10A | NM_006514.4 | c.2428G>T | p.Gly810Trp | missense_variant | Exon 16 of 28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.2428G>T | p.Gly810Trp | missense_variant | Exon 16 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.2428G>T | p.Gly810Trp | missense_variant | Exon 15 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.2455G>T | p.Gly819Trp | missense_variant | Exon 16 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000284 AC: 71AN: 250354 AF XY: 0.000295 show subpopulations
GnomAD4 exome AF: 0.000605 AC: 885AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.000579 AC XY: 421AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000282 AC: 43AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74460 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Episodic pain syndrome, familial, 2 Uncertain:3
- -
- -
- -
not provided Uncertain:2Benign:1
p.Gly810Trp (G810W; c.2428G>T) in exon 15 of the SCN10A gene (NM_006514.3) Chromosome location 3:38770245 C / A Found in a 12-year-old male with a history of 2 unexplained syncopal episodes and a run of monomorphic VT on Holter monitor. Based on the information reviewed below, including a lack of case data, and prevalence in the broader population, we classify this as a VUS, Probably Benign. This variant is most common among individuals with Latino ancestry like our patient, and it may therefore be a benign ethnicity-specific variant. This variant has previously been reported in a European-American male individual diagnosed at age 51 with paroxysmal atrial fibrillation (PMID: 25053638). There is no published segregation data. This is a conservative amino acid change, resulting in the replacement of a nonpolar Glycine with a nonpolar Tryptophan that has a much larger side chain. Glycine at this location is highly conserved across ~100 vertebrate species for which we have data, although it is a Serine in two mammalian species and an Arginine in another. The adjacent residues are not highly conserved. There are no Likely Pathogenic or Pathogenic variants listed in ClinVar within 10 amino acids to either side, indicating that this region of the protein might be tolerant of change. According to the Invitae report, algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant was reported in 75 individuals in the gnomAD database, which includes variant calls on ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. Specifically, the variant was observed in 17 Latino individuals (for the highest allele frequency: 0.05%), 56 non-Finnish Europeans (MAF 0.04%), and 2 individuals with African ancestry. (There are also 2 individuals with p.Gly810Arg.) Invitae’s report notes that it has an allele count higher than expected for a pathogenic variant. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. -
Reported in association with paroxysmal atrial fibrillation and small fiber neuropathy (PMID: 25053638, 36895957); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36895957, 25053638) -
SCN10A: BS2 -
Brugada syndrome Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 810 of the SCN10A protein (p.Gly810Trp). This variant is present in population databases (rs145712124, gnomAD 0.05%). This missense change has been observed in individual(s) with atrial fibrillation or small fiber neuropathy and/or epilepsy (PMID: 25053638, 36895957, 37993639). ClinVar contains an entry for this variant (Variation ID: 463239). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SCN10A protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Benign:1
Variant summary: SCN10A c.2428G>T (p.Gly810Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 250354 control chromosomes, predominantly at a frequency of 0.00049 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 78 fold of the estimated maximal expected allele frequency for a pathogenic variant in SCN10A causing Arrhythmia phenotype (6.3e-06). To our knowledge, no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 463239). Based on the evidence outlined above, the variant was classified as likely benign. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at